Global Next Generation Cancer Diagnostics Market Research Report 2025(Status and Outlook)
The global Next Generation Cancer Diagnostics market size was estimated at USD 8826.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 18.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Next Generation Cancer Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Next Generation Cancer Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Next Generation Cancer Diagnostics market.
Global Next Generation Cancer Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Market Segmentation (by Type)
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Next Generation Cancer Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Next Generation Cancer Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Next Generation Cancer Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Next Generation Cancer Diagnostics market.
Global Next Generation Cancer Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Market Segmentation (by Type)
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Next Generation Cancer Diagnostics Market
- Overview of the regional outlook of the Next Generation Cancer Diagnostics Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Next Generation Cancer Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Next Generation Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Next Generation Cancer Diagnostics Segment by Type
1.2.2 Next Generation Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEXT GENERATION CANCER DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Next Generation Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Next Generation Cancer Diagnostics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEXT GENERATION CANCER DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Next Generation Cancer Diagnostics Product Life Cycle
3.3 Global Next Generation Cancer Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Next Generation Cancer Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Next Generation Cancer Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Next Generation Cancer Diagnostics Market Competitive Situation and Trends
3.8.1 Next Generation Cancer Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Next Generation Cancer Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEXT GENERATION CANCER DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Next Generation Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEXT GENERATION CANCER DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Next Generation Cancer Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Next Generation Cancer Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Cancer Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2020-2025)
6.4 Global Next Generation Cancer Diagnostics Price by Type (2020-2025)
7 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Cancer Diagnostics Market Sales by Application (2020-2025)
7.3 Global Next Generation Cancer Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2020-2025)
8 NEXT GENERATION CANCER DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.2 Global Next Generation Cancer Diagnostics Sales Market Share by Region
8.2 Global Next Generation Cancer Diagnostics Market Size by Region
8.2.1 Global Next Generation Cancer Diagnostics Market Size by Region
8.2.2 Global Next Generation Cancer Diagnostics Market Size Market Share by Region
8.3 North America
8.3.1 North America Next Generation Cancer Diagnostics Sales by Country
8.3.2 North America Next Generation Cancer Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Next Generation Cancer Diagnostics Sales by Country
8.4.2 Europe Next Generation Cancer Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Next Generation Cancer Diagnostics Sales by Region
8.5.2 Asia Pacific Next Generation Cancer Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Next Generation Cancer Diagnostics Sales by Country
8.6.2 South America Next Generation Cancer Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Next Generation Cancer Diagnostics Sales by Region
8.7.2 Middle East and Africa Next Generation Cancer Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEXT GENERATION CANCER DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Next Generation Cancer Diagnostics by Region(2020-2025)
9.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Next Generation Cancer Diagnostics Production
9.4.1 North America Next Generation Cancer Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Next Generation Cancer Diagnostics Production
9.5.1 Europe Next Generation Cancer Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Next Generation Cancer Diagnostics Production (2020-2025)
9.6.1 Japan Next Generation Cancer Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Next Generation Cancer Diagnostics Production (2020-2025)
9.7.1 China Next Generation Cancer Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cepheid
10.1.1 Cepheid Basic Information
10.1.2 Cepheid Next Generation Cancer Diagnostics Product Overview
10.1.3 Cepheid Next Generation Cancer Diagnostics Product Market Performance
10.1.4 Cepheid Business Overview
10.1.5 Cepheid SWOT Analysis
10.1.6 Cepheid Recent Developments
10.2 Koninklijke Philips N.V
10.2.1 Koninklijke Philips N.V Basic Information
10.2.2 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Overview
10.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Market Performance
10.2.4 Koninklijke Philips N.V Business Overview
10.2.5 Koninklijke Philips N.V SWOT Analysis
10.2.6 Koninklijke Philips N.V Recent Developments
10.3 F. Hoffmann-La Roche Ltd
10.3.1 F. Hoffmann-La Roche Ltd Basic Information
10.3.2 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Overview
10.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Market Performance
10.3.4 F. Hoffmann-La Roche Ltd Business Overview
10.3.5 F. Hoffmann-La Roche Ltd SWOT Analysis
10.3.6 F. Hoffmann-La Roche Ltd Recent Developments
10.4 Qiagen
10.4.1 Qiagen Basic Information
10.4.2 Qiagen Next Generation Cancer Diagnostics Product Overview
10.4.3 Qiagen Next Generation Cancer Diagnostics Product Market Performance
10.4.4 Qiagen Business Overview
10.4.5 Qiagen Recent Developments
10.5 Novartis AG
10.5.1 Novartis AG Basic Information
10.5.2 Novartis AG Next Generation Cancer Diagnostics Product Overview
10.5.3 Novartis AG Next Generation Cancer Diagnostics Product Market Performance
10.5.4 Novartis AG Business Overview
10.5.5 Novartis AG Recent Developments
10.6 Abbott
10.6.1 Abbott Basic Information
10.6.2 Abbott Next Generation Cancer Diagnostics Product Overview
10.6.3 Abbott Next Generation Cancer Diagnostics Product Market Performance
10.6.4 Abbott Business Overview
10.6.5 Abbott Recent Developments
10.7 Thermo Fisher Scientific
10.7.1 Thermo Fisher Scientific Basic Information
10.7.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Overview
10.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Market Performance
10.7.4 Thermo Fisher Scientific Business Overview
10.7.5 Thermo Fisher Scientific Recent Developments
10.8 Opko Health
10.8.1 Opko Health Basic Information
10.8.2 Opko Health Next Generation Cancer Diagnostics Product Overview
10.8.3 Opko Health Next Generation Cancer Diagnostics Product Market Performance
10.8.4 Opko Health Business Overview
10.8.5 Opko Health Recent Developments
10.9 Myriad Genetics
10.9.1 Myriad Genetics Basic Information
10.9.2 Myriad Genetics Next Generation Cancer Diagnostics Product Overview
10.9.3 Myriad Genetics Next Generation Cancer Diagnostics Product Market Performance
10.9.4 Myriad Genetics Business Overview
10.9.5 Myriad Genetics Recent Developments
10.10 Agilent Technologies
10.10.1 Agilent Technologies Basic Information
10.10.2 Agilent Technologies Next Generation Cancer Diagnostics Product Overview
10.10.3 Agilent Technologies Next Generation Cancer Diagnostics Product Market Performance
10.10.4 Agilent Technologies Business Overview
10.10.5 Agilent Technologies Recent Developments
10.11 GE Healthcare
10.11.1 GE Healthcare Basic Information
10.11.2 GE Healthcare Next Generation Cancer Diagnostics Product Overview
10.11.3 GE Healthcare Next Generation Cancer Diagnostics Product Market Performance
10.11.4 GE Healthcare Business Overview
10.11.5 GE Healthcare Recent Developments
10.12 PerkinElmer
10.12.1 PerkinElmer Basic Information
10.12.2 PerkinElmer Next Generation Cancer Diagnostics Product Overview
10.12.3 PerkinElmer Next Generation Cancer Diagnostics Product Market Performance
10.12.4 PerkinElmer Business Overview
10.12.5 PerkinElmer Recent Developments
10.13 Genomic Health
10.13.1 Genomic Health Basic Information
10.13.2 Genomic Health Next Generation Cancer Diagnostics Product Overview
10.13.3 Genomic Health Next Generation Cancer Diagnostics Product Market Performance
10.13.4 Genomic Health Business Overview
10.13.5 Genomic Health Recent Developments
10.14 Illumina
10.14.1 Illumina Basic Information
10.14.2 Illumina Next Generation Cancer Diagnostics Product Overview
10.14.3 Illumina Next Generation Cancer Diagnostics Product Market Performance
10.14.4 Illumina Business Overview
10.14.5 Illumina Recent Developments
10.15 Hologic
10.15.1 Hologic Basic Information
10.15.2 Hologic Next Generation Cancer Diagnostics Product Overview
10.15.3 Hologic Next Generation Cancer Diagnostics Product Market Performance
10.15.4 Hologic Business Overview
10.15.5 Hologic Recent Developments
10.16 Almac Group
10.16.1 Almac Group Basic Information
10.16.2 Almac Group Next Generation Cancer Diagnostics Product Overview
10.16.3 Almac Group Next Generation Cancer Diagnostics Product Market Performance
10.16.4 Almac Group Business Overview
10.16.5 Almac Group Recent Developments
10.17 Janssen Global Services
10.17.1 Janssen Global Services Basic Information
10.17.2 Janssen Global Services Next Generation Cancer Diagnostics Product Overview
10.17.3 Janssen Global Services Next Generation Cancer Diagnostics Product Market Performance
10.17.4 Janssen Global Services Business Overview
10.17.5 Janssen Global Services Recent Developments
10.18 Sysmex Corporation
10.18.1 Sysmex Corporation Basic Information
10.18.2 Sysmex Corporation Next Generation Cancer Diagnostics Product Overview
10.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Product Market Performance
10.18.4 Sysmex Corporation Business Overview
10.18.5 Sysmex Corporation Recent Developments
11 NEXT GENERATION CANCER DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Next Generation Cancer Diagnostics Market Size Forecast
11.2 Global Next Generation Cancer Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Next Generation Cancer Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Next Generation Cancer Diagnostics Market Size Forecast by Region
11.2.4 South America Next Generation Cancer Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Next Generation Cancer Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Next Generation Cancer Diagnostics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Next Generation Cancer Diagnostics by Type (2026-2033)
12.1.2 Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Next Generation Cancer Diagnostics by Type (2026-2033)
12.2 Global Next Generation Cancer Diagnostics Market Forecast by Application (2026-2033)
12.2.1 Global Next Generation Cancer Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Next Generation Cancer Diagnostics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Next Generation Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Next Generation Cancer Diagnostics Segment by Type
1.2.2 Next Generation Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEXT GENERATION CANCER DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Next Generation Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Next Generation Cancer Diagnostics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEXT GENERATION CANCER DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Next Generation Cancer Diagnostics Product Life Cycle
3.3 Global Next Generation Cancer Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Next Generation Cancer Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Next Generation Cancer Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Next Generation Cancer Diagnostics Market Competitive Situation and Trends
3.8.1 Next Generation Cancer Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Next Generation Cancer Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEXT GENERATION CANCER DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Next Generation Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEXT GENERATION CANCER DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Next Generation Cancer Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Next Generation Cancer Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Cancer Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2020-2025)
6.4 Global Next Generation Cancer Diagnostics Price by Type (2020-2025)
7 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Cancer Diagnostics Market Sales by Application (2020-2025)
7.3 Global Next Generation Cancer Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2020-2025)
8 NEXT GENERATION CANCER DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.2 Global Next Generation Cancer Diagnostics Sales Market Share by Region
8.2 Global Next Generation Cancer Diagnostics Market Size by Region
8.2.1 Global Next Generation Cancer Diagnostics Market Size by Region
8.2.2 Global Next Generation Cancer Diagnostics Market Size Market Share by Region
8.3 North America
8.3.1 North America Next Generation Cancer Diagnostics Sales by Country
8.3.2 North America Next Generation Cancer Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Next Generation Cancer Diagnostics Sales by Country
8.4.2 Europe Next Generation Cancer Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Next Generation Cancer Diagnostics Sales by Region
8.5.2 Asia Pacific Next Generation Cancer Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Next Generation Cancer Diagnostics Sales by Country
8.6.2 South America Next Generation Cancer Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Next Generation Cancer Diagnostics Sales by Region
8.7.2 Middle East and Africa Next Generation Cancer Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEXT GENERATION CANCER DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Next Generation Cancer Diagnostics by Region(2020-2025)
9.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Next Generation Cancer Diagnostics Production
9.4.1 North America Next Generation Cancer Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Next Generation Cancer Diagnostics Production
9.5.1 Europe Next Generation Cancer Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Next Generation Cancer Diagnostics Production (2020-2025)
9.6.1 Japan Next Generation Cancer Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Next Generation Cancer Diagnostics Production (2020-2025)
9.7.1 China Next Generation Cancer Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cepheid
10.1.1 Cepheid Basic Information
10.1.2 Cepheid Next Generation Cancer Diagnostics Product Overview
10.1.3 Cepheid Next Generation Cancer Diagnostics Product Market Performance
10.1.4 Cepheid Business Overview
10.1.5 Cepheid SWOT Analysis
10.1.6 Cepheid Recent Developments
10.2 Koninklijke Philips N.V
10.2.1 Koninklijke Philips N.V Basic Information
10.2.2 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Overview
10.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Market Performance
10.2.4 Koninklijke Philips N.V Business Overview
10.2.5 Koninklijke Philips N.V SWOT Analysis
10.2.6 Koninklijke Philips N.V Recent Developments
10.3 F. Hoffmann-La Roche Ltd
10.3.1 F. Hoffmann-La Roche Ltd Basic Information
10.3.2 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Overview
10.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Market Performance
10.3.4 F. Hoffmann-La Roche Ltd Business Overview
10.3.5 F. Hoffmann-La Roche Ltd SWOT Analysis
10.3.6 F. Hoffmann-La Roche Ltd Recent Developments
10.4 Qiagen
10.4.1 Qiagen Basic Information
10.4.2 Qiagen Next Generation Cancer Diagnostics Product Overview
10.4.3 Qiagen Next Generation Cancer Diagnostics Product Market Performance
10.4.4 Qiagen Business Overview
10.4.5 Qiagen Recent Developments
10.5 Novartis AG
10.5.1 Novartis AG Basic Information
10.5.2 Novartis AG Next Generation Cancer Diagnostics Product Overview
10.5.3 Novartis AG Next Generation Cancer Diagnostics Product Market Performance
10.5.4 Novartis AG Business Overview
10.5.5 Novartis AG Recent Developments
10.6 Abbott
10.6.1 Abbott Basic Information
10.6.2 Abbott Next Generation Cancer Diagnostics Product Overview
10.6.3 Abbott Next Generation Cancer Diagnostics Product Market Performance
10.6.4 Abbott Business Overview
10.6.5 Abbott Recent Developments
10.7 Thermo Fisher Scientific
10.7.1 Thermo Fisher Scientific Basic Information
10.7.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Overview
10.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Market Performance
10.7.4 Thermo Fisher Scientific Business Overview
10.7.5 Thermo Fisher Scientific Recent Developments
10.8 Opko Health
10.8.1 Opko Health Basic Information
10.8.2 Opko Health Next Generation Cancer Diagnostics Product Overview
10.8.3 Opko Health Next Generation Cancer Diagnostics Product Market Performance
10.8.4 Opko Health Business Overview
10.8.5 Opko Health Recent Developments
10.9 Myriad Genetics
10.9.1 Myriad Genetics Basic Information
10.9.2 Myriad Genetics Next Generation Cancer Diagnostics Product Overview
10.9.3 Myriad Genetics Next Generation Cancer Diagnostics Product Market Performance
10.9.4 Myriad Genetics Business Overview
10.9.5 Myriad Genetics Recent Developments
10.10 Agilent Technologies
10.10.1 Agilent Technologies Basic Information
10.10.2 Agilent Technologies Next Generation Cancer Diagnostics Product Overview
10.10.3 Agilent Technologies Next Generation Cancer Diagnostics Product Market Performance
10.10.4 Agilent Technologies Business Overview
10.10.5 Agilent Technologies Recent Developments
10.11 GE Healthcare
10.11.1 GE Healthcare Basic Information
10.11.2 GE Healthcare Next Generation Cancer Diagnostics Product Overview
10.11.3 GE Healthcare Next Generation Cancer Diagnostics Product Market Performance
10.11.4 GE Healthcare Business Overview
10.11.5 GE Healthcare Recent Developments
10.12 PerkinElmer
10.12.1 PerkinElmer Basic Information
10.12.2 PerkinElmer Next Generation Cancer Diagnostics Product Overview
10.12.3 PerkinElmer Next Generation Cancer Diagnostics Product Market Performance
10.12.4 PerkinElmer Business Overview
10.12.5 PerkinElmer Recent Developments
10.13 Genomic Health
10.13.1 Genomic Health Basic Information
10.13.2 Genomic Health Next Generation Cancer Diagnostics Product Overview
10.13.3 Genomic Health Next Generation Cancer Diagnostics Product Market Performance
10.13.4 Genomic Health Business Overview
10.13.5 Genomic Health Recent Developments
10.14 Illumina
10.14.1 Illumina Basic Information
10.14.2 Illumina Next Generation Cancer Diagnostics Product Overview
10.14.3 Illumina Next Generation Cancer Diagnostics Product Market Performance
10.14.4 Illumina Business Overview
10.14.5 Illumina Recent Developments
10.15 Hologic
10.15.1 Hologic Basic Information
10.15.2 Hologic Next Generation Cancer Diagnostics Product Overview
10.15.3 Hologic Next Generation Cancer Diagnostics Product Market Performance
10.15.4 Hologic Business Overview
10.15.5 Hologic Recent Developments
10.16 Almac Group
10.16.1 Almac Group Basic Information
10.16.2 Almac Group Next Generation Cancer Diagnostics Product Overview
10.16.3 Almac Group Next Generation Cancer Diagnostics Product Market Performance
10.16.4 Almac Group Business Overview
10.16.5 Almac Group Recent Developments
10.17 Janssen Global Services
10.17.1 Janssen Global Services Basic Information
10.17.2 Janssen Global Services Next Generation Cancer Diagnostics Product Overview
10.17.3 Janssen Global Services Next Generation Cancer Diagnostics Product Market Performance
10.17.4 Janssen Global Services Business Overview
10.17.5 Janssen Global Services Recent Developments
10.18 Sysmex Corporation
10.18.1 Sysmex Corporation Basic Information
10.18.2 Sysmex Corporation Next Generation Cancer Diagnostics Product Overview
10.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Product Market Performance
10.18.4 Sysmex Corporation Business Overview
10.18.5 Sysmex Corporation Recent Developments
11 NEXT GENERATION CANCER DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Next Generation Cancer Diagnostics Market Size Forecast
11.2 Global Next Generation Cancer Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Next Generation Cancer Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Next Generation Cancer Diagnostics Market Size Forecast by Region
11.2.4 South America Next Generation Cancer Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Next Generation Cancer Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Next Generation Cancer Diagnostics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Next Generation Cancer Diagnostics by Type (2026-2033)
12.1.2 Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Next Generation Cancer Diagnostics by Type (2026-2033)
12.2 Global Next Generation Cancer Diagnostics Market Forecast by Application (2026-2033)
12.2.1 Global Next Generation Cancer Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Next Generation Cancer Diagnostics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Next Generation Cancer Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Next Generation Cancer Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Next Generation Cancer Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Next Generation Cancer Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Next Generation Cancer Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2024)
Table 10. Global Market Next Generation Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Next Generation Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Next Generation Cancer Diagnostics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Next Generation Cancer Diagnostics Sales by Type (K Units)
Table 26. Global Next Generation Cancer Diagnostics Market Size by Type (M USD)
Table 27. Global Next Generation Cancer Diagnostics Sales (K Units) by Type (2020-2025)
Table 28. Global Next Generation Cancer Diagnostics Sales Market Share by Type (2020-2025)
Table 29. Global Next Generation Cancer Diagnostics Market Size (M USD) by Type (2020-2025)
Table 30. Global Next Generation Cancer Diagnostics Market Size Share by Type (2020-2025)
Table 31. Global Next Generation Cancer Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Next Generation Cancer Diagnostics Sales (K Units) by Application
Table 33. Global Next Generation Cancer Diagnostics Market Size by Application
Table 34. Global Next Generation Cancer Diagnostics Sales by Application (2020-2025) & (K Units)
Table 35. Global Next Generation Cancer Diagnostics Sales Market Share by Application (2020-2025)
Table 36. Global Next Generation Cancer Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Next Generation Cancer Diagnostics Market Share by Application (2020-2025)
Table 38. Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2020-2025)
Table 39. Global Next Generation Cancer Diagnostics Sales by Region (2020-2025) & (K Units)
Table 40. Global Next Generation Cancer Diagnostics Sales Market Share by Region (2020-2025)
Table 41. Global Next Generation Cancer Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Next Generation Cancer Diagnostics Market Size Market Share by Region (2020-2025)
Table 43. North America Next Generation Cancer Diagnostics Sales by Country (2020-2025) & (K Units)
Table 44. North America Next Generation Cancer Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Next Generation Cancer Diagnostics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Next Generation Cancer Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Next Generation Cancer Diagnostics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Next Generation Cancer Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Next Generation Cancer Diagnostics Sales by Country (2020-2025) & (K Units)
Table 50. South America Next Generation Cancer Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Next Generation Cancer Diagnostics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Next Generation Cancer Diagnostics Production (K Units) by Region(2020-2025)
Table 54. Global Next Generation Cancer Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Next Generation Cancer Diagnostics Revenue Market Share by Region (2020-2025)
Table 56. Global Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Cepheid Basic Information
Table 62. Cepheid Next Generation Cancer Diagnostics Product Overview
Table 63. Cepheid Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Cepheid Business Overview
Table 65. Cepheid SWOT Analysis
Table 66. Cepheid Recent Developments
Table 67. Koninklijke Philips N.V Basic Information
Table 68. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Overview
Table 69. Koninklijke Philips N.V Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Koninklijke Philips N.V Business Overview
Table 71. Koninklijke Philips N.V SWOT Analysis
Table 72. Koninklijke Philips N.V Recent Developments
Table 73. F. Hoffmann-La Roche Ltd Basic Information
Table 74. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Overview
Table 75. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. F. Hoffmann-La Roche Ltd Business Overview
Table 77. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 78. F. Hoffmann-La Roche Ltd Recent Developments
Table 79. Qiagen Basic Information
Table 80. Qiagen Next Generation Cancer Diagnostics Product Overview
Table 81. Qiagen Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Qiagen Business Overview
Table 83. Qiagen Recent Developments
Table 84. Novartis AG Basic Information
Table 85. Novartis AG Next Generation Cancer Diagnostics Product Overview
Table 86. Novartis AG Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Recent Developments
Table 89. Abbott Basic Information
Table 90. Abbott Next Generation Cancer Diagnostics Product Overview
Table 91. Abbott Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Abbott Business Overview
Table 93. Abbott Recent Developments
Table 94. Thermo Fisher Scientific Basic Information
Table 95. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Overview
Table 96. Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Thermo Fisher Scientific Business Overview
Table 98. Thermo Fisher Scientific Recent Developments
Table 99. Opko Health Basic Information
Table 100. Opko Health Next Generation Cancer Diagnostics Product Overview
Table 101. Opko Health Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Opko Health Business Overview
Table 103. Opko Health Recent Developments
Table 104. Myriad Genetics Basic Information
Table 105. Myriad Genetics Next Generation Cancer Diagnostics Product Overview
Table 106. Myriad Genetics Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Myriad Genetics Business Overview
Table 108. Myriad Genetics Recent Developments
Table 109. Agilent Technologies Basic Information
Table 110. Agilent Technologies Next Generation Cancer Diagnostics Product Overview
Table 111. Agilent Technologies Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Agilent Technologies Business Overview
Table 113. Agilent Technologies Recent Developments
Table 114. GE Healthcare Basic Information
Table 115. GE Healthcare Next Generation Cancer Diagnostics Product Overview
Table 116. GE Healthcare Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. GE Healthcare Business Overview
Table 118. GE Healthcare Recent Developments
Table 119. PerkinElmer Basic Information
Table 120. PerkinElmer Next Generation Cancer Diagnostics Product Overview
Table 121. PerkinElmer Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. PerkinElmer Business Overview
Table 123. PerkinElmer Recent Developments
Table 124. Genomic Health Basic Information
Table 125. Genomic Health Next Generation Cancer Diagnostics Product Overview
Table 126. Genomic Health Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Genomic Health Business Overview
Table 128. Genomic Health Recent Developments
Table 129. Illumina Basic Information
Table 130. Illumina Next Generation Cancer Diagnostics Product Overview
Table 131. Illumina Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Illumina Business Overview
Table 133. Illumina Recent Developments
Table 134. Hologic Basic Information
Table 135. Hologic Next Generation Cancer Diagnostics Product Overview
Table 136. Hologic Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Hologic Business Overview
Table 138. Hologic Recent Developments
Table 139. Almac Group Basic Information
Table 140. Almac Group Next Generation Cancer Diagnostics Product Overview
Table 141. Almac Group Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Almac Group Business Overview
Table 143. Almac Group Recent Developments
Table 144. Janssen Global Services Basic Information
Table 145. Janssen Global Services Next Generation Cancer Diagnostics Product Overview
Table 146. Janssen Global Services Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Janssen Global Services Business Overview
Table 148. Janssen Global Services Recent Developments
Table 149. Sysmex Corporation Basic Information
Table 150. Sysmex Corporation Next Generation Cancer Diagnostics Product Overview
Table 151. Sysmex Corporation Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Sysmex Corporation Business Overview
Table 153. Sysmex Corporation Recent Developments
Table 154. Global Next Generation Cancer Diagnostics Sales Forecast by Region (2026-2033) & (K Units)
Table 155. Global Next Generation Cancer Diagnostics Market Size Forecast by Region (2026-2033) & (M USD)
Table 156. North America Next Generation Cancer Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 157. North America Next Generation Cancer Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 158. Europe Next Generation Cancer Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 159. Europe Next Generation Cancer Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 160. Asia Pacific Next Generation Cancer Diagnostics Sales Forecast by Region (2026-2033) & (K Units)
Table 161. Asia Pacific Next Generation Cancer Diagnostics Market Size Forecast by Region (2026-2033) & (M USD)
Table 162. South America Next Generation Cancer Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 163. South America Next Generation Cancer Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 164. Middle East and Africa Next Generation Cancer Diagnostics Sales Forecast by Country (2026-2033) & (Units)
Table 165. Middle East and Africa Next Generation Cancer Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 166. Global Next Generation Cancer Diagnostics Sales Forecast by Type (2026-2033) & (K Units)
Table 167. Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2026-2033) & (M USD)
Table 168. Global Next Generation Cancer Diagnostics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 169. Global Next Generation Cancer Diagnostics Sales (K Units) Forecast by Application (2026-2033)
Table 170. Global Next Generation Cancer Diagnostics Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Next Generation Cancer Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Next Generation Cancer Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Next Generation Cancer Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Next Generation Cancer Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Next Generation Cancer Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2024)
Table 10. Global Market Next Generation Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Next Generation Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Next Generation Cancer Diagnostics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Next Generation Cancer Diagnostics Sales by Type (K Units)
Table 26. Global Next Generation Cancer Diagnostics Market Size by Type (M USD)
Table 27. Global Next Generation Cancer Diagnostics Sales (K Units) by Type (2020-2025)
Table 28. Global Next Generation Cancer Diagnostics Sales Market Share by Type (2020-2025)
Table 29. Global Next Generation Cancer Diagnostics Market Size (M USD) by Type (2020-2025)
Table 30. Global Next Generation Cancer Diagnostics Market Size Share by Type (2020-2025)
Table 31. Global Next Generation Cancer Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Next Generation Cancer Diagnostics Sales (K Units) by Application
Table 33. Global Next Generation Cancer Diagnostics Market Size by Application
Table 34. Global Next Generation Cancer Diagnostics Sales by Application (2020-2025) & (K Units)
Table 35. Global Next Generation Cancer Diagnostics Sales Market Share by Application (2020-2025)
Table 36. Global Next Generation Cancer Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Next Generation Cancer Diagnostics Market Share by Application (2020-2025)
Table 38. Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2020-2025)
Table 39. Global Next Generation Cancer Diagnostics Sales by Region (2020-2025) & (K Units)
Table 40. Global Next Generation Cancer Diagnostics Sales Market Share by Region (2020-2025)
Table 41. Global Next Generation Cancer Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Next Generation Cancer Diagnostics Market Size Market Share by Region (2020-2025)
Table 43. North America Next Generation Cancer Diagnostics Sales by Country (2020-2025) & (K Units)
Table 44. North America Next Generation Cancer Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Next Generation Cancer Diagnostics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Next Generation Cancer Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Next Generation Cancer Diagnostics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Next Generation Cancer Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Next Generation Cancer Diagnostics Sales by Country (2020-2025) & (K Units)
Table 50. South America Next Generation Cancer Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Next Generation Cancer Diagnostics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Next Generation Cancer Diagnostics Production (K Units) by Region(2020-2025)
Table 54. Global Next Generation Cancer Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Next Generation Cancer Diagnostics Revenue Market Share by Region (2020-2025)
Table 56. Global Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Next Generation Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Cepheid Basic Information
Table 62. Cepheid Next Generation Cancer Diagnostics Product Overview
Table 63. Cepheid Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Cepheid Business Overview
Table 65. Cepheid SWOT Analysis
Table 66. Cepheid Recent Developments
Table 67. Koninklijke Philips N.V Basic Information
Table 68. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Overview
Table 69. Koninklijke Philips N.V Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Koninklijke Philips N.V Business Overview
Table 71. Koninklijke Philips N.V SWOT Analysis
Table 72. Koninklijke Philips N.V Recent Developments
Table 73. F. Hoffmann-La Roche Ltd Basic Information
Table 74. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Overview
Table 75. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. F. Hoffmann-La Roche Ltd Business Overview
Table 77. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 78. F. Hoffmann-La Roche Ltd Recent Developments
Table 79. Qiagen Basic Information
Table 80. Qiagen Next Generation Cancer Diagnostics Product Overview
Table 81. Qiagen Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Qiagen Business Overview
Table 83. Qiagen Recent Developments
Table 84. Novartis AG Basic Information
Table 85. Novartis AG Next Generation Cancer Diagnostics Product Overview
Table 86. Novartis AG Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Recent Developments
Table 89. Abbott Basic Information
Table 90. Abbott Next Generation Cancer Diagnostics Product Overview
Table 91. Abbott Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Abbott Business Overview
Table 93. Abbott Recent Developments
Table 94. Thermo Fisher Scientific Basic Information
Table 95. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Overview
Table 96. Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Thermo Fisher Scientific Business Overview
Table 98. Thermo Fisher Scientific Recent Developments
Table 99. Opko Health Basic Information
Table 100. Opko Health Next Generation Cancer Diagnostics Product Overview
Table 101. Opko Health Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Opko Health Business Overview
Table 103. Opko Health Recent Developments
Table 104. Myriad Genetics Basic Information
Table 105. Myriad Genetics Next Generation Cancer Diagnostics Product Overview
Table 106. Myriad Genetics Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Myriad Genetics Business Overview
Table 108. Myriad Genetics Recent Developments
Table 109. Agilent Technologies Basic Information
Table 110. Agilent Technologies Next Generation Cancer Diagnostics Product Overview
Table 111. Agilent Technologies Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Agilent Technologies Business Overview
Table 113. Agilent Technologies Recent Developments
Table 114. GE Healthcare Basic Information
Table 115. GE Healthcare Next Generation Cancer Diagnostics Product Overview
Table 116. GE Healthcare Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. GE Healthcare Business Overview
Table 118. GE Healthcare Recent Developments
Table 119. PerkinElmer Basic Information
Table 120. PerkinElmer Next Generation Cancer Diagnostics Product Overview
Table 121. PerkinElmer Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. PerkinElmer Business Overview
Table 123. PerkinElmer Recent Developments
Table 124. Genomic Health Basic Information
Table 125. Genomic Health Next Generation Cancer Diagnostics Product Overview
Table 126. Genomic Health Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Genomic Health Business Overview
Table 128. Genomic Health Recent Developments
Table 129. Illumina Basic Information
Table 130. Illumina Next Generation Cancer Diagnostics Product Overview
Table 131. Illumina Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Illumina Business Overview
Table 133. Illumina Recent Developments
Table 134. Hologic Basic Information
Table 135. Hologic Next Generation Cancer Diagnostics Product Overview
Table 136. Hologic Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Hologic Business Overview
Table 138. Hologic Recent Developments
Table 139. Almac Group Basic Information
Table 140. Almac Group Next Generation Cancer Diagnostics Product Overview
Table 141. Almac Group Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Almac Group Business Overview
Table 143. Almac Group Recent Developments
Table 144. Janssen Global Services Basic Information
Table 145. Janssen Global Services Next Generation Cancer Diagnostics Product Overview
Table 146. Janssen Global Services Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Janssen Global Services Business Overview
Table 148. Janssen Global Services Recent Developments
Table 149. Sysmex Corporation Basic Information
Table 150. Sysmex Corporation Next Generation Cancer Diagnostics Product Overview
Table 151. Sysmex Corporation Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Sysmex Corporation Business Overview
Table 153. Sysmex Corporation Recent Developments
Table 154. Global Next Generation Cancer Diagnostics Sales Forecast by Region (2026-2033) & (K Units)
Table 155. Global Next Generation Cancer Diagnostics Market Size Forecast by Region (2026-2033) & (M USD)
Table 156. North America Next Generation Cancer Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 157. North America Next Generation Cancer Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 158. Europe Next Generation Cancer Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 159. Europe Next Generation Cancer Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 160. Asia Pacific Next Generation Cancer Diagnostics Sales Forecast by Region (2026-2033) & (K Units)
Table 161. Asia Pacific Next Generation Cancer Diagnostics Market Size Forecast by Region (2026-2033) & (M USD)
Table 162. South America Next Generation Cancer Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 163. South America Next Generation Cancer Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 164. Middle East and Africa Next Generation Cancer Diagnostics Sales Forecast by Country (2026-2033) & (Units)
Table 165. Middle East and Africa Next Generation Cancer Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 166. Global Next Generation Cancer Diagnostics Sales Forecast by Type (2026-2033) & (K Units)
Table 167. Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2026-2033) & (M USD)
Table 168. Global Next Generation Cancer Diagnostics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 169. Global Next Generation Cancer Diagnostics Sales (K Units) Forecast by Application (2026-2033)
Table 170. Global Next Generation Cancer Diagnostics Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Next Generation Cancer Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Next Generation Cancer Diagnostics Market Size (M USD), 2024-2033
Figure 5. Global Next Generation Cancer Diagnostics Market Size (M USD) (2020-2033)
Figure 6. Global Next Generation Cancer Diagnostics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Next Generation Cancer Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Next Generation Cancer Diagnostics Product Life Cycle
Figure 13. Next Generation Cancer Diagnostics Sales Share by Manufacturers in 2024
Figure 14. Global Next Generation Cancer Diagnostics Revenue Share by Manufacturers in 2024
Figure 15. Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Next Generation Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Next Generation Cancer Diagnostics Revenue in 2024
Figure 18. Industry Chain Map of Next Generation Cancer Diagnostics
Figure 19. Global Next Generation Cancer Diagnostics Market PEST Analysis
Figure 20. Global Next Generation Cancer Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Next Generation Cancer Diagnostics Market Share by Type
Figure 27. Sales Market Share of Next Generation Cancer Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Next Generation Cancer Diagnostics by Type in 2024
Figure 29. Market Size Share of Next Generation Cancer Diagnostics by Type (2020-2025)
Figure 30. Market Size Share of Next Generation Cancer Diagnostics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Next Generation Cancer Diagnostics Market Share by Application
Figure 33. Global Next Generation Cancer Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Next Generation Cancer Diagnostics Sales Market Share by Application in 2024
Figure 35. Global Next Generation Cancer Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Next Generation Cancer Diagnostics Market Share by Application in 2024
Figure 37. Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Next Generation Cancer Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Next Generation Cancer Diagnostics Market Size Market Share by Region (2020-2025)
Figure 40. North America Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Next Generation Cancer Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Next Generation Cancer Diagnostics Market Size Market Share by Country in 2024
Figure 45. U.S. Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Next Generation Cancer Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Next Generation Cancer Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Next Generation Cancer Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Next Generation Cancer Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Next Generation Cancer Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Next Generation Cancer Diagnostics Market Size Market Share by Country in 2024
Figure 55. Germany Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Next Generation Cancer Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Next Generation Cancer Diagnostics Market Size Market Share by Region in 2024
Figure 68. China Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Next Generation Cancer Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Next Generation Cancer Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Next Generation Cancer Diagnostics Market Size Market Share by Country in 2024
Figure 82. Brazil Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Next Generation Cancer Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Next Generation Cancer Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Next Generation Cancer Diagnostics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Next Generation Cancer Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Next Generation Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Next Generation Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Next Generation Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Next Generation Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Next Generation Cancer Diagnostics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Next Generation Cancer Diagnostics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Next Generation Cancer Diagnostics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Next Generation Cancer Diagnostics Market Share Forecast by Type (2026-2033)
Figure 111. Global Next Generation Cancer Diagnostics Sales Forecast by Application (2026-2033)
Figure 112. Global Next Generation Cancer Diagnostics Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Next Generation Cancer Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Next Generation Cancer Diagnostics Market Size (M USD), 2024-2033
Figure 5. Global Next Generation Cancer Diagnostics Market Size (M USD) (2020-2033)
Figure 6. Global Next Generation Cancer Diagnostics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Next Generation Cancer Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Next Generation Cancer Diagnostics Product Life Cycle
Figure 13. Next Generation Cancer Diagnostics Sales Share by Manufacturers in 2024
Figure 14. Global Next Generation Cancer Diagnostics Revenue Share by Manufacturers in 2024
Figure 15. Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Next Generation Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Next Generation Cancer Diagnostics Revenue in 2024
Figure 18. Industry Chain Map of Next Generation Cancer Diagnostics
Figure 19. Global Next Generation Cancer Diagnostics Market PEST Analysis
Figure 20. Global Next Generation Cancer Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Next Generation Cancer Diagnostics Market Share by Type
Figure 27. Sales Market Share of Next Generation Cancer Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Next Generation Cancer Diagnostics by Type in 2024
Figure 29. Market Size Share of Next Generation Cancer Diagnostics by Type (2020-2025)
Figure 30. Market Size Share of Next Generation Cancer Diagnostics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Next Generation Cancer Diagnostics Market Share by Application
Figure 33. Global Next Generation Cancer Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Next Generation Cancer Diagnostics Sales Market Share by Application in 2024
Figure 35. Global Next Generation Cancer Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Next Generation Cancer Diagnostics Market Share by Application in 2024
Figure 37. Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Next Generation Cancer Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Next Generation Cancer Diagnostics Market Size Market Share by Region (2020-2025)
Figure 40. North America Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Next Generation Cancer Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Next Generation Cancer Diagnostics Market Size Market Share by Country in 2024
Figure 45. U.S. Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Next Generation Cancer Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Next Generation Cancer Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Next Generation Cancer Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Next Generation Cancer Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Next Generation Cancer Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Next Generation Cancer Diagnostics Market Size Market Share by Country in 2024
Figure 55. Germany Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Next Generation Cancer Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Next Generation Cancer Diagnostics Market Size Market Share by Region in 2024
Figure 68. China Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Next Generation Cancer Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Next Generation Cancer Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Next Generation Cancer Diagnostics Market Size Market Share by Country in 2024
Figure 82. Brazil Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Next Generation Cancer Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Next Generation Cancer Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Next Generation Cancer Diagnostics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Next Generation Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Next Generation Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Next Generation Cancer Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Next Generation Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Next Generation Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Next Generation Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Next Generation Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Next Generation Cancer Diagnostics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Next Generation Cancer Diagnostics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Next Generation Cancer Diagnostics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Next Generation Cancer Diagnostics Market Share Forecast by Type (2026-2033)
Figure 111. Global Next Generation Cancer Diagnostics Sales Forecast by Application (2026-2033)
Figure 112. Global Next Generation Cancer Diagnostics Market Share Forecast by Application (2026-2033)
